Legend Biotech (LEGN)
(Real Time Quote from BATS)
$37.39 USD
-0.27 (-0.72%)
Updated Aug 7, 2025 09:58 AM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Legend Biotech Corporation Sponsored ADR has a market cap of $6.92B, which represents its share price of $37.66 multiplied by its outstanding shares number of 183.76M. As a mid-cap company, LEGN's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
LEGN 37.39 -0.27(-0.72%)
Will LEGN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for LEGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LEGN
Legend Biotech (LEGN) Surges 6.0%: Is This an Indication of Further Gains?
What Makes Legend Biotech (LEGN) a New Buy Stock
LEGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Think Legend Biotech (LEGN) Could Surge 135.16%: Read This Before Placing a Bet
Legend Biotech (LEGN) Moves 5.1% Higher: Will This Strength Last?
Pacira (PCRX) Surges 14.7%: Is This an Indication of Further Gains?
Other News for LEGN
Why Johnson & Johnson Stock Still Has Room To Run
Legend Biotech to Host Investor Conference Call on Second Quarter 2025 Results | LEGN Stock News
Legend Biotech Corp (LEGN) Announces Upcoming Conference Call to Discuss Q2 2025 Results | LEGN ...
Looking Into Legend Biotech's Recent Short Interest
Legend Biotech (LEGN) Receives 'Buy' Rating from HC Wainwright & Co. | LEGN Stock News